What is the prevalence of Dermatofibrosarcoma Protuberans (DFSP)?

Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing soft tissue sarcoma with an estimated annual incidence of approximately 0.8 to 4.5 cases per million people. While considered rare, Dermatofibrosarcoma protuberans (DFSP) is the most common cutaneous sarcoma, though true prevalence data remains difficult to pinpoint due to frequent initial misdiagnosis as benign skin lesions.

Who is most commonly affected by Dermatofibrosarcoma protuberans (DFSP)?

Dermatofibrosarcoma protuberans (DFSP) typically presents in young to middle-aged adults, with a median age of onset between 30 and 50 years. While cases are rare in children, pediatric Dermatofibrosarcoma protuberans (DFSP) does occur and can be particularly challenging to identify. Clinical data generally suggests a similar incidence rate across genders, though some studies indicate a slightly higher frequency in women. Ethnic or geographic variations are not strongly established in current literature, though the condition is reported globally.

Why is accurate data on Dermatofibrosarcoma protuberans (DFSP) prevalence challenging?

Obtaining precise statistics for Dermatofibrosarcoma protuberans (DFSP) is complicated by several factors:

• Misdiagnosis: Because Dermatofibrosarcoma protuberans (DFSP) often appears as a firm, flesh-colored plaque or scar-like lesion, it is frequently mistaken for keloids, dermatofibromas, or lipomas.


• Slow Progression: The tumor’s indolent, slow-growing nature often leads to significant delays in seeking medical attention, resulting in under-reporting in cancer registries.


• Rare Disease Coding: As an ultra-rare or rare condition in many regions, centralized data collection is often limited compared to more common malignancies.

How does the DiseaseMaps community reflect the experience of Dermatofibrosarcoma protuberans (DFSP)?

At DiseaseMaps.org, we currently have 172 members who have shared their journey with Dermatofibrosarcoma protuberans (DFSP). This real-world community data highlights that while medical literature classifies this as a "rare" disease, the collective patient experience provides vital insights into the diagnostic odyssey and the burden of living with a recurring, locally aggressive tumor.

Next steps

• Consult a dermatologist or an oncologist specializing in soft tissue sarcomas for any persistent or changing skin lesions.


• Request a referral to a sarcoma center of excellence for biopsy and histopathological confirmation.


• Connect with the 172 members at DiseaseMaps.org to share experiences and receive peer support.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• Orphanet (ORPHA:1393) - Rare disease information on Dermatofibrosarcoma Protuberans.


• NIH Genetic and Rare Diseases Information Center (GARD) - Overview of DFSP.


• National Cancer Institute (NCI) - Surveillance, Epidemiology, and End Results (SEER) program data on rare soft tissue sarcomas.


• OMIM (Online Mendelian Inheritance in Man) - Molecular genetics of DFSP (Entry #607131).